Cannabis, psychedelics, and the profit motive that blocks psychiatric drugs from reaching patients
Gabriella Gobbi, MD, PhD, McGill University, Canada. Dr. Gabriella Gobbi paddling on the Adriatic Sea at dawn. Gabriella Gobbi: Embracing psychiatry from bench to bedside Research links adolescent cannabis use to depression, advances a first-in-class sleep drug, and pioneers psychedelic neuroscience We may lose good, non-expensive treatments because it is profit, not science, that controls ...
Read More